Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1992 | 1 |
1993 | 1 |
2008 | 2 |
2010 | 2 |
2011 | 1 |
2014 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Inhaled drugs as risk factors for community-acquired pneumonia.
Eur Respir J. 2010 Nov;36(5):1080-7. doi: 10.1183/09031936.00022909. Epub 2010 Jun 4.
Eur Respir J. 2010.
PMID: 20525710
Free article.
Identifying effective pathways in a successful continuous quality improvement programme: the GEDAPS study.
Bodicoat DH, Mundet X, Gray LJ, Cos X, Davies MJ, Khunti K, Cano JF; GEDAPS Study Group.
Bodicoat DH, et al.
J Eval Clin Pract. 2014 Dec;20(6):1137-43. doi: 10.1111/jep.12253. Epub 2014 Sep 29.
J Eval Clin Pract. 2014.
PMID: 25266778
Item in Clipboard
New evidence of risk factors for community-acquired pneumonia: a population-based study.
Almirall J, Bolíbar I, Serra-Prat M, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Torres A; Community-Acquired Pneumonia in Catalan Countries (PACAP) Study Group.
Almirall J, et al.
Eur Respir J. 2008 Jun;31(6):1274-84. doi: 10.1183/09031936.00095807. Epub 2008 Jan 23.
Eur Respir J. 2008.
PMID: 18216057
Free article.
Item in Clipboard
Randomized clinical trial to assess the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in general practice: the PREseAP study.
Brotons C, Soriano N, Moral I, Rodrigo MP, Kloppe P, Rodríguez AI, González ML, Ariño D, Orozco D, Buitrago F, Pepió JM, Borrás I; PREseAP study research team.
Brotons C, et al.
Rev Esp Cardiol. 2011 Jan;64(1):13-20. doi: 10.1016/j.recesp.2010.07.005. Epub 2010 Dec 30.
Rev Esp Cardiol. 2011.
PMID: 21194823
Free article.
Clinical Trial.
Item in Clipboard
[Factors affecting the control of blood pressure and lipid levels in patients with cardiovascular disease: the PREseAP Study].
Orozco-Beltrán D, Brotons C, Moral I, Soriano N, Del Valle MA, Rodríguez AI, Pepió JM, Pastor A; investigadores del estudio PREseAP.
Orozco-Beltrán D, et al.
Rev Esp Cardiol. 2008 Mar;61(3):317-21.
Rev Esp Cardiol. 2008.
PMID: 18361907
Free article.
Spanish.
Item in Clipboard
[Consumption of drugs in diabetes mellitus II. Utilization and loss of insulin: epidemiologic and socioeconomic implications. Study Group for Diabetes in Tarragona (GEDT)].
Costa B, Monclús JF, Huguet M.
Costa B, et al. Among authors: monclus jf.
Med Clin (Barc). 1993 Feb 20;100(7):241-4.
Med Clin (Barc). 1993.
PMID: 8433583
Spanish.
Item in Clipboard
[Drug consumption in diabetes mellitus (I). Estimate of the therapeutic profile and the prevalence in the regions of Tarragona (548,900 inhabitants). Grup per a l'Estudi de la Diabetis a Tarragona].
Costa B, Utgés P, Monclús JF, Gomis T, Ciurana MR, Julve P.
Costa B, et al. Among authors: monclus jf.
Med Clin (Barc). 1992 Sep 19;99(8):294-9.
Med Clin (Barc). 1992.
PMID: 1453822
Spanish.
Item in Clipboard
Cite
Cite